Mortality trends in multiple myeloma and cardiovascular disease in the US (1999–2020).
Abstract
e23056 Background: Multiple Myeloma (MM) and cardiovascular disease (CVD) significantly contribute to mortality in the U.S. This study examines mortality trends from 1999 to 2020, focusing on demographic and geographic disparities. Methods: CDC WONDER data for U.S. adults (≥25 years) from 1999 to 2020 were analyzed. Age-adjusted mortality rates (AAMRs) per million were calculated by gender, race/ethnicity, census region, urbanization level, and state. Joinpoint regression estimated average annual percentage change (AAPC) with 95% confidence intervals (CIs) to assess statistical significance. Results: MM and CVD caused 101,225 deaths, with an overall AAMR of 21.29/million (95% CI 21.16–21.42). AAMRs ranged from 19.72/million (2013) to 23.58/million (2020). The overall trend was stable (AAPC: 0.15%; 95% CI -0.14 to 0.46; p = 0.2807), but mortality increased significantly from 2018–2020 (APC: 6.96%; 95% CI 3.08–9.16; p < 0.000001). Males had higher mortality (56,591 deaths) than females (44,634 deaths). Male AAMRs were 29.33/million (1999) and 28.44/million (2020), while female AAMRs declined from 18.56/million (1999) to 16.25/million (2020). Trends showed a significant decline in females (AAPC: -0.76%; 95% CI -1.28 to -0.37; p < 0.000001) and an increase in males (AAPC: 0.47%; 95% CI 0.27–0.71; p < 0.000001). Racial disparities were evident, with the highest AAMRs in Blacks (45.45/million; 95% CI 44.79–46.10), followed by Whites (19.02/million), Hispanics (19.43/million), and Asians (12.3/million). Mortality declined significantly for Asians (AAPC: -1.52%; 95% CI -2.23 to -0.60; p = 0.0008) and Hispanics (AAPC: -0.72%; 95% CI -1.30 to -0.06; p = 0.038), while trends in Blacks and Whites were not significant. Conclusions: Despite a stable overall trend, male mortality increased, and racial disparities persisted, particularly among Black populations. Targeted interventions are needed to address mortality inequities in high-risk groups. Cohort Age Adjusted Mortality Rate per Million Average Annual Percentage Change 95% Confidence Interval P- Value Overall 21.29 0.1516 -0.1423 to 0.458 0.280744 Female 16.25 -0.7637* -1.2818 to -0.3695 < 0.000001 Male 28.44 0.4728* 0.2666 to 0.7071 < 0.000001 Asian or Pacific Islander 12.3 -1.5233* -2.231 to -0.5963 0.0008 Black or African American 45.45 -0.0821 -0.839 to 0.3407 0.737852 White 19.02 0.2266 -0.0659 to 0.5538 0.111978 Hispanic or Latino 19.43 -0.7208* -1.3047 to -0.0615 0.037992
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (13)
Kainat Aman
Batterjaee Medical College, Jeddah, Saudi Arabia
Faizan Ahmed
Aman Ullah
Najam Gohar
Ameer-ud-Din Medical College, Sialkot, Pakistan
Abdullah Zia
6Ameer-ud-din Medical College, Lahore, Pakistan
Yusra Junaid
Dow Medical College, Karachi, Pakistan
Hira Zahid
Dow Medical College, Karachi, Pakistan
Areehah Zafar Masood
Ziauddin Medical University, Karachi, Pakistan
Omar Kamel
South valley university, Sohag, Egypt
Mohammad Hossain
Sherif Eltawansy
Mohamed Bakr
Jersey Shore, New Jersey, NJ
Adnan Bhat
University of Florida, Gainesville, FL